ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hospice and Palliative Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,746Medicare Part D Prescriptions Filled, Including Refills
$618K Total Retail Price of All Prescriptions
589 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
OMEPRAZOLE 357 296
METFORMIN HCL 343 299
LISINOPRIL 278 247
CRESTOR 277 247
SIMVASTATIN 268 225
TRAMADOL HCL 243 209
IBUPROFEN 233 204
METOPROLOL TARTRATE 227 215
NEXIUM 221 165
GABAPENTIN 214 192
AMLODIPINE BESYLATE 205 176
DONEPEZIL HCL 204 193
LEVOTHYROXINE SODIUM 188 173
LIDODERM 171 135
FUROSEMIDE 164 164
AZITHROMYCIN 160 137
DIOVAN HCT 148 137
DIOVAN 144 107
RANITIDINE HCL 138 135
ADVAIR DISKUS 134 119
CLOPIDOGREL 134 116
VOLTAREN 132 103
SINGULAIR 130 117
PLAVIX 125 105
HYDROCHLOROTHIAZIDE 118 101
MECLIZINE HCL 111 103
ATENOLOL 107 104
VIAGRA 104 94
NAMENDA 101 100
LANSOPRAZOLE 99 96
LANTUS 96 72
CARVEDILOL 93 93
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 74
DICYCLOMINE HCL 89 88
LOVASTATIN 82 82
GLYBURIDE 79 79 R
ESCITALOPRAM OXALATE 77 71
TEMAZEPAM 77 71
LEXAPRO 71 60
METOCLOPRAMIDE HCL 70 64
LOVAZA 67 67
AMLODIPINE BESYLATE-BENAZEPRIL 67 55
LOSARTAN POTASSIUM 66 60
INSULIN SYRINGE 63 49
VITAMIN D2 63 58
GEMFIBROZIL 63 52
CIPROFLOXACIN HCL 62 50
PENTOXIFYLLINE 58 58
TAMSULOSIN HCL 57 56
ENALAPRIL MALEATE 57 53
NAPROXEN 57 52
NITROSTAT 55 45
ALPRAZOLAM 53 44
MONTELUKAST SODIUM 52 44
CYPROHEPTADINE HCL 52 52 R
DEXILANT 51 47
AVODART 51 51
POTASSIUM CHLORIDE 50 50
DOXAZOSIN MESYLATE 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.